Elevated hemoglobin A1c levels are associated with worse survival in advanced pancreatic cancer patients with diabetes

Gut and Liver

Volumn 8, Issue 2, 2014, Pages 205-214

  Cheon, Young Koog ^a   Koo, Ja Kyung ^a   Lee, Yoon Serk ^a   Lee, Tae Yoon ^a   Shim, Chan Sup ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

Diabetes mellitus; Glycosylated hemoglobin A; Metformin; Pancreatic neoplasms

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CA 19-9 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; HEMOGLOBIN A1C; METFORMIN; GLYCOSYLATED HEMOGLOBIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PANCREAS CANCER; RETROSPECTIVE STUDY; SURVIVAL FACTOR; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; VERY ELDERLY; BLOOD; COMPLICATION; EPIDEMIOLOGY; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; PANCREAS TUMOR; PROGNOSIS; SOUTH KOREA;

ADULT; AGED; AGED, 80 AND OVER; DIABETES COMPLICATIONS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 84896925144     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2014.8.2.205     Document Type: Article

References (36)

1. Hidalgo M. Pancreatic cancer. N Engl J Med 2010;362:1605-1617.
2. Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an update. Dig Dis 2010;28:645-656.
3. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 1995;273:1605-1609.
4. Pannala R, Leirness JB, Bamlet WR, Basu A, Petersen GM, Chari ST. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 2008;134:981-987. (Pubitemid 351451984)
5. Wang F, Gupta S, Holly EA. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev 2006;15:1458-1463. (Pubitemid 44299315)
6. Noy A, Bilezikian JP. Clinical review 63: diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy. J Clin Endocrinol Metab 1994;79:1223-1231.
7. Chari ST, Leibson CL, Rabe KG, et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008;134:95-101. (Pubitemid 350309328)
8. Barone BB, Yeh HC, Snyder CF, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 2008;300:2754-2764.
9. van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 2007;120:1986-1992.
10. Chu CK, Mazo AE, Goodman M, et al. Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma. Ann Surg Oncol 2010;17:502-513.
11. Cannon RM, LeGrand R, Chagpar RB, et al. Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection. HPB (Oxford) 2012;14:228-235.
12. Smith GD, Egger M, Shipley MJ, Marmot MG. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. Am J Epidemiol 1992;136:1110-1114. (Pubitemid 23005170)
13. Rohlfing CL, Little RR, Wiedmeyer HM, et al. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 2000;23:187-191. (Pubitemid 30071022)
14. Nakanishi S, Yamada M, Hattori N, Suzuki G. Relationship between HbA(1)c and mortality in a Japanese population. Diabetologia 2005;48:230-234. (Pubitemid 40543294)
15. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer- Norfolk study. Cancer Epidemiol Biomarkers Prev 2004;13:915-919. (Pubitemid 38756700)
16. American Diabetes Association. Standards of medical care in diabetes: 2012. Diabetes Care 2012;35 Suppl 1:S11-S63.
17. Gullo L, Pezzilli R, Morselli-Labate AM; Italian Pancreatic Cancer Study Group. Diabetes and the risk of pancreatic cancer. N Engl J Med 1994;331:81-84. (Pubitemid 24202222)
18. Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 1980;45:2220-2224. (Pubitemid 10150440)
19. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-240. (Pubitemid 29056916)
20. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005;293:194-202. (Pubitemid 40095870)
21. Chow WH, Gridley G, Nyrén O, et al. Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst 1995;87:930-931.
22. Calle EE, Murphy TK, Rodriguez C, Thun MJ, Heath CW Jr. Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control 1998;9:403-410. (Pubitemid 28466692)
23. Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 2000;283:2552-2558. (Pubitemid 30324198)
24. Goldstein DE, Little RR, Lorenz RA, et al. Tests of glycemia in diabetes. Diabetes Care 2004;27:1761-1773. (Pubitemid 38857461)
25. Richardson LC, Pollack LA. Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol 2005;2:48-53. (Pubitemid 40823181)
26. Fisher WE, Boros LG, Schirmer WJ. Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors. J Surg Res 1996;63:310-313. (Pubitemid 26197211)
27. Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med 1997;336:633-640.
28. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Järvinen H, Karonen SL, Seppälä M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 1988;66:266-272. (Pubitemid 18065166)
29. Meyerhardt JA, Catalano PJ, Haller DG, et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 2003;21:433-440. (Pubitemid 46606471)
30. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001;44 Suppl 2:S14-S21. (Pubitemid 32844108)
31. Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005;330:1304-1305. (Pubitemid 40813563)
32. Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 2006;29:254-258. (Pubitemid 44106500)
33. El-Mir MY, Nogueira V, Fontaine E, Avéret N, Rigoulet M, Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 2000;275:223-228. (Pubitemid 30038975)
34. Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001;108:1167-1174. (Pubitemid 32995375)
35. Martin M, Marais R. Metformin: a diabetes drug for cancer, or a cancer drug for diabetics? J Clin Oncol 2012;30:2698-2700.
36. Williams T, Brenman JE. LKB1 and AMPK in cell polarity and division. Trends Cell Biol 2008;18:193-198.